-
Allergan Sales, LLC et al v. Breckenridge Pharmaceutical, Inc. DC
- 1:20-cv-00199
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 02/10/2020
- Closed: 11/18/2020
- Latest Docket Entry: 11/18/2020
- PACER
- Docket updated daily
3
Plaintiffs
1
Defendant
3
Accused
Products
2
Patents-in-Suit
283
Days in
Litigation
-
Allergan Sales, LLC et al v. Breckenridge Pharmaceutical, Inc. DC
- 1:20-cv-00199
- D. Del.
- Judge: Mitchell S. Goldberg
- Filed: 02/10/2020
- Closed: 11/18/2020
- Latest Docket Entry: 11/18/2020
- PACER
- Docket updated daily
Causes of Action
Infringement
Declaratory Judgment
Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A pharmaceutical composition comprising as a medicinally active compound: trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1H-dibenzÂ2,3:6,7!oxepinoÂ4,5-c!pyrrole or a pharmaceutically acceptable salt thereof; wherein the composition is a solid
view more
|
Valid
Entry 13 |
2 |
The pharmaceutical composition of claim 1, wherein the composition further comprises a pharmaceutically acceptable water-soluble or water-dispersable carrier material.
|
Valid
Entry 13 |
4 |
A method for treating tension, excitation, anxiety, and psychotic and schizophrenic disorders, comprising administering sublingually or buccally an effective amount of a pharmaceutical composition comprising
view more
|
Valid
Entry 13 |
5 |
The pharmaceutical composition of claim 1, wherein the composition disintegrates within 10 seconds in water at 37.degree. C.
|
Valid
Entry 13 |
6 |
The composition of claim 1, further comprising one or more pharmaceutically acceptable auxiliaries selected from the group consisting of hydrolyzed dextran, dextrin, mannitol, algenates, polyvinyl alcohol, polyvinyl pyrrolidine and water soluble
view more
|
Valid
Entry 13 |
9 |
The method of claim 4, wherein the composition is a solid pharmaceutical composition which rapidly disintegrates in the mouth of a subject upon insertion into the buccal pouch or upon placement under the tongue.
|
Valid
Entry 13 |
10 |
The method of claim 4, wherein the pharmaceutical composition further comprises pharmaceutically acceptable auxiliaries selected from the group consisting of hydrolyzed dextran, dextrin, mannitol, algenates, polyvinyl alcohol, polyvinyl
view more
|
Valid
Entry 13 |
-
Infringement
Breckenridge Pharmaceutical, Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
asenapine maleate tablets equiv. 10 mg baseasenapine maleate tablets equiv. to 2.5 mg baseasenapine maleate tablets equiv. to 5 mg base | US 5,763,476 A |
1, 2, 4, 5, 6, 9, 10
|
Infringement
Entry 13
|